NO20034538L - Anvendelsen av enantiomer ren escitalopram - Google Patents

Anvendelsen av enantiomer ren escitalopram

Info

Publication number
NO20034538L
NO20034538L NO20034538A NO20034538A NO20034538L NO 20034538 L NO20034538 L NO 20034538L NO 20034538 A NO20034538 A NO 20034538A NO 20034538 A NO20034538 A NO 20034538A NO 20034538 L NO20034538 L NO 20034538L
Authority
NO
Norway
Prior art keywords
enantiomeric pure
pure escitalopram
escitalopram
enantiomeric
pure
Prior art date
Application number
NO20034538A
Other languages
English (en)
Other versions
NO20034538D0 (no
Inventor
Connie Sanchez
Arne Mork
Jesper Lyng Jensen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20034538D0 publication Critical patent/NO20034538D0/no
Publication of NO20034538L publication Critical patent/NO20034538L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
NO20034538A 2001-05-01 2003-10-09 Anvendelsen av enantiomer ren escitalopram NO20034538L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100684 2001-05-01
PCT/DK2002/000281 WO2002087566A1 (en) 2001-05-01 2002-05-01 The use of enantiomeric pure escitalopram

Publications (2)

Publication Number Publication Date
NO20034538D0 NO20034538D0 (no) 2003-10-09
NO20034538L true NO20034538L (no) 2003-10-09

Family

ID=8160464

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034538A NO20034538L (no) 2001-05-01 2003-10-09 Anvendelsen av enantiomer ren escitalopram

Country Status (25)

Country Link
US (7) US20040198809A1 (no)
EP (1) EP1385503A1 (no)
JP (1) JP2004527551A (no)
KR (2) KR20040030609A (no)
CN (1) CN1509169A (no)
AR (1) AR033308A1 (no)
AT (1) AT10974U1 (no)
BG (1) BG108379A (no)
BR (1) BR0208283A (no)
CA (1) CA2445843A1 (no)
CZ (1) CZ20033267A3 (no)
EA (1) EA200301195A1 (no)
HR (1) HRP20030744A2 (no)
HU (1) HUP0400054A3 (no)
IL (1) IL158031A0 (no)
IS (1) IS6954A (no)
ME (1) MEP5908A (no)
MX (1) MXPA03008777A (no)
NO (1) NO20034538L (no)
PL (1) PL367480A1 (no)
SK (1) SK14612003A3 (no)
UA (1) UA82828C2 (no)
WO (1) WO2002087566A1 (no)
YU (1) YU85303A (no)
ZA (1) ZA200307102B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US20040198809A1 (en) * 2001-05-01 2004-10-07 Connie Sanchez Use of enantiomeric pure escitalopram
DK1578738T3 (da) * 2002-12-23 2008-06-30 Lundbeck & Co As H Escitalopram-hydrobromid og fremgangsmåde til fremstilling deraf
US20050037983A1 (en) * 2003-03-11 2005-02-17 Timothy Dinan Compositions and methods for the treatment of depression and other affective disorders
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
DK1691811T3 (da) * 2003-12-11 2014-10-20 Sunovion Pharmaceuticals Inc Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
US20050196453A1 (en) 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
AU2005218713B2 (en) * 2004-03-05 2009-11-19 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
ZA200804086B (en) * 2005-10-14 2009-07-29 Lundbeck & Co As H Stable pharmaceutical formulations containing escitalo-pram and bupropion
JP2009511606A (ja) * 2005-10-14 2009-03-19 ハー・ルンドベック・アクチエゼルスカベット エスシタロプラムおよびブプロピオンの低用量の併用を用いる中枢神経系障害の治療方法
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
US20070259952A1 (en) * 2006-05-02 2007-11-08 H. Lundbeck A/S Uses of escitalopram
EP2086509A1 (en) * 2006-10-20 2009-08-12 Ratiopharm GmbH Escitalopram and solid pharmaceutical composition comprising the same
US20100003313A1 (en) * 2006-10-27 2010-01-07 Hisamitsu Pharmaceutical Co.,Inc. Adhesive skin patch
EP2017271A1 (en) 2007-07-06 2009-01-21 Aurobindo Pharma Limited Process for the preparation of escitalopram
ES2653852T3 (es) * 2007-08-03 2018-02-09 Richter Gedeon Nyrt. Composiciones farmacéuticas que contienen ligandos del receptor de dopamina y procedimientos de tratamiento usando ligandos del receptor de dopamina
US20100331402A1 (en) * 2008-01-31 2010-12-30 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder
ITMI20080768A1 (it) * 2008-04-24 2009-10-25 Abiogen Pharma Spa Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one
WO2010098230A1 (ja) * 2009-02-27 2010-09-02 久光製薬株式会社 経皮投与製剤
US20180071269A1 (en) 2015-08-12 2018-03-15 Tianxin Wang Therapeutical methods, formulations and nutraceutical formulations
WO2016180879A1 (en) * 2015-05-13 2016-11-17 A. Carlsson Research Ab Treatment of debilitating fatigue

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (no) * 1965-03-18
US4079135A (en) * 1973-12-13 1978-03-14 Imperial Chemical Industries Limited Morpholine derivatives as antidepressants
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8607313D0 (en) * 1986-03-25 1986-04-30 Ici Plc Pharmaceutical compositions
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US4902710A (en) * 1988-12-14 1990-02-20 Eli Lilly And Company Serotonin and norepinephrine uptake inhibitors
US5114976A (en) * 1989-01-06 1992-05-19 Norden Michael J Method for treating certain psychiatric disorders and certain psychiatric symptoms
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5554383A (en) * 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
US5846982A (en) * 1996-06-14 1998-12-08 Eli Lilly And Company Inhibition of serotonin reuptake
US5747494A (en) * 1996-06-28 1998-05-05 U C B S.A. Pharmaceutical compositions for the treatment of depressive disorders
US5958429A (en) * 1996-08-16 1999-09-28 Eli Lilly And Company Potentiation of serotonin response
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders
US6069177A (en) * 1997-07-08 2000-05-30 The Hong Kong University Of Science And Technology 3-Hydroxy-propanamine derived neuronal reuptake inhibitors
SE9703375D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
BR9714925A (pt) * 1997-11-11 2003-07-22 Lundbeck & Co As H Método para preparação de citalopran, composto e composição farmacêutica antidepressiva
CA2334897A1 (en) * 1998-06-30 2000-01-06 Eli Lilly And Company Pyrrolidine and pyrroline derivatives having effects on serotonin related systems
US6150376A (en) * 1998-08-05 2000-11-21 Georgetown University Bi- and tri-cyclic aza compounds and their uses
CZ299920B6 (cs) * 1998-10-20 2008-12-29 H. Lundbeck A/S Zpusob výroby citalopramu
CN1142926C (zh) * 1999-04-14 2004-03-24 H·隆德贝克有限公司 制备西酞普兰的方法
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
AU2001255654B2 (en) * 2000-04-24 2005-09-22 Aryx Therapeutics Materials and methods for the treatment of depression
US20040198809A1 (en) * 2001-05-01 2004-10-07 Connie Sanchez Use of enantiomeric pure escitalopram

Also Published As

Publication number Publication date
HRP20030744A2 (en) 2005-06-30
BG108379A (bg) 2004-11-30
HUP0400054A2 (hu) 2004-04-28
HUP0400054A3 (en) 2007-03-28
JP2004527551A (ja) 2004-09-09
US20040198810A1 (en) 2004-10-07
AR033308A1 (es) 2003-12-10
NO20034538D0 (no) 2003-10-09
UA82828C2 (en) 2008-05-26
CZ20033267A3 (en) 2004-06-16
EP1385503A1 (en) 2004-02-04
CA2445843A1 (en) 2002-11-07
WO2002087566A1 (en) 2002-11-07
US20040198811A1 (en) 2004-10-07
KR20100012089A (ko) 2010-02-05
US20080004338A1 (en) 2008-01-03
CN1509169A (zh) 2004-06-30
MEP5908A (xx) 2010-02-10
PL367480A1 (en) 2005-02-21
US20040198809A1 (en) 2004-10-07
SK14612003A3 (sk) 2004-04-06
IL158031A0 (en) 2004-03-28
KR20040030609A (ko) 2004-04-09
US20040192766A1 (en) 2004-09-30
IS6954A (is) 2003-09-15
MXPA03008777A (es) 2004-02-12
AT10974U1 (de) 2010-02-15
US20040192765A1 (en) 2004-09-30
ZA200307102B (en) 2004-09-13
BR0208283A (pt) 2004-03-09
EA200301195A1 (ru) 2004-04-29
US20040192764A1 (en) 2004-09-30
YU85303A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
NO20034538L (no) Anvendelsen av enantiomer ren escitalopram
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20031494D0 (no) Bestemmelse av brudd-lukningstrykk
DE60202737D1 (de) Kappenanordnung
IS6971A (is) Ný efnasambönd
NO20011272L (no) Fremgangsmåte for fremstilling av ren citalopram
NO20011271A (no) Fremgangsmåte for fremstilling av ren citalopram
BR0201972B1 (pt) montante de suspensão.
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
LU91603I2 (fr) Eslicarbazepine acetate (Zebinix - eslicarbazepineacetate) Composé: énantiomère S de la Licarbazepi ne
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
DE60224290D1 (de) Herstellung von metallrohren
DE50212400D1 (de) Lastschaltbare Mehrgangnabe
ATE286478T1 (de) Verschlusskappe
NO20041200L (no) Fremgangsmate for fremstilling av citalopram.
NO20041968L (no) Anvendelse av cystationin
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
DE60126053D1 (de) Applikator
EE200400016A (et) Protsess 1,5-diarüül-3-trifluorometüül-delta²-pürasoliinide ratseemiliste ja enantiomeerselt puhaste derivaatide valmistamiseks
NO20033163L (no) Ny anvendelse av iloperidon
ATA922001A (de) Vorsatzschale
DE50203590D1 (de) Applikator
DE50204437D1 (de) Borstenbremsring
UA5955S (uk) Комбінований ковпачок

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application